Cargando…

Facilitators and barriers for tuberculosis preventive treatment among patients with latent tuberculosis infection: a qualitative study

BACKGROUND: Various factors influence tuberculosis preventive treatment (TPT) decisions thus it is important to understand the health beliefs and concerns of patients before starting TPT to ensure treatment compliance. This study aims to explore facilitators and barriers for TPT among patients diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Manoharan, Anusha, Siti Nur Farhana, H., Manimaran, K., Khoo, Ee Ming, Koh, Wen Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517541/
https://www.ncbi.nlm.nih.gov/pubmed/37740196
http://dx.doi.org/10.1186/s12879-023-08612-2
_version_ 1785109345691762688
author Manoharan, Anusha
Siti Nur Farhana, H.
Manimaran, K.
Khoo, Ee Ming
Koh, Wen Ming
author_facet Manoharan, Anusha
Siti Nur Farhana, H.
Manimaran, K.
Khoo, Ee Ming
Koh, Wen Ming
author_sort Manoharan, Anusha
collection PubMed
description BACKGROUND: Various factors influence tuberculosis preventive treatment (TPT) decisions thus it is important to understand the health beliefs and concerns of patients before starting TPT to ensure treatment compliance. This study aims to explore facilitators and barriers for TPT among patients diagnosed with Latent Tuberculosis infection (LTBI) attending six primary healthcare clinics in Selangor, Malaysia. METHOD: In-depth interviews were conducted face-to-face or via telephone among patients with a clinical diagnosis of LTBI using a semi-structured topic guide developed based on the common-sense model of self-regulation and literature review. Audio recordings of interviews were transcribed verbatim and analysed thematically. RESULTS: We conducted 26 In-depth interviews; Good knowledge of active tuberculosis (TB) and its associated complications, including the perceived seriousness and transmissibility of active TB, facilitates treatment. LTBI is viewed as a concern when immune status is compromised, thus fostering TPT. However, optimal health is a barrier for TPT. Owing to the lack of knowledge, patients rely on healthcare practitioners (HCPs) to determine their treatment paths. HCPs possessing comprehensive knowledge play a role in facilitating TPT whereas barriers to TPT encompass misinterpretation of tuberculin skin test (TST), inadequate explanation of TST, and apprehensions about potential medication side effects. CONCLUSIONS: Knowledge of LTBI can influence TPT uptake and patients often entrust their HCPs for treatment decisions. Improving knowledge of LTBI both among patients and HCPs can lead to more effective doctor-patient consultation and consequently boost the acceptance of TPT. Quality assurance should be enhanced to ensure the effective usage of TST as a screening tool.
format Online
Article
Text
id pubmed-10517541
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105175412023-09-24 Facilitators and barriers for tuberculosis preventive treatment among patients with latent tuberculosis infection: a qualitative study Manoharan, Anusha Siti Nur Farhana, H. Manimaran, K. Khoo, Ee Ming Koh, Wen Ming BMC Infect Dis Research BACKGROUND: Various factors influence tuberculosis preventive treatment (TPT) decisions thus it is important to understand the health beliefs and concerns of patients before starting TPT to ensure treatment compliance. This study aims to explore facilitators and barriers for TPT among patients diagnosed with Latent Tuberculosis infection (LTBI) attending six primary healthcare clinics in Selangor, Malaysia. METHOD: In-depth interviews were conducted face-to-face or via telephone among patients with a clinical diagnosis of LTBI using a semi-structured topic guide developed based on the common-sense model of self-regulation and literature review. Audio recordings of interviews were transcribed verbatim and analysed thematically. RESULTS: We conducted 26 In-depth interviews; Good knowledge of active tuberculosis (TB) and its associated complications, including the perceived seriousness and transmissibility of active TB, facilitates treatment. LTBI is viewed as a concern when immune status is compromised, thus fostering TPT. However, optimal health is a barrier for TPT. Owing to the lack of knowledge, patients rely on healthcare practitioners (HCPs) to determine their treatment paths. HCPs possessing comprehensive knowledge play a role in facilitating TPT whereas barriers to TPT encompass misinterpretation of tuberculin skin test (TST), inadequate explanation of TST, and apprehensions about potential medication side effects. CONCLUSIONS: Knowledge of LTBI can influence TPT uptake and patients often entrust their HCPs for treatment decisions. Improving knowledge of LTBI both among patients and HCPs can lead to more effective doctor-patient consultation and consequently boost the acceptance of TPT. Quality assurance should be enhanced to ensure the effective usage of TST as a screening tool. BioMed Central 2023-09-22 /pmc/articles/PMC10517541/ /pubmed/37740196 http://dx.doi.org/10.1186/s12879-023-08612-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Manoharan, Anusha
Siti Nur Farhana, H.
Manimaran, K.
Khoo, Ee Ming
Koh, Wen Ming
Facilitators and barriers for tuberculosis preventive treatment among patients with latent tuberculosis infection: a qualitative study
title Facilitators and barriers for tuberculosis preventive treatment among patients with latent tuberculosis infection: a qualitative study
title_full Facilitators and barriers for tuberculosis preventive treatment among patients with latent tuberculosis infection: a qualitative study
title_fullStr Facilitators and barriers for tuberculosis preventive treatment among patients with latent tuberculosis infection: a qualitative study
title_full_unstemmed Facilitators and barriers for tuberculosis preventive treatment among patients with latent tuberculosis infection: a qualitative study
title_short Facilitators and barriers for tuberculosis preventive treatment among patients with latent tuberculosis infection: a qualitative study
title_sort facilitators and barriers for tuberculosis preventive treatment among patients with latent tuberculosis infection: a qualitative study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517541/
https://www.ncbi.nlm.nih.gov/pubmed/37740196
http://dx.doi.org/10.1186/s12879-023-08612-2
work_keys_str_mv AT manoharananusha facilitatorsandbarriersfortuberculosispreventivetreatmentamongpatientswithlatenttuberculosisinfectionaqualitativestudy
AT sitinurfarhanah facilitatorsandbarriersfortuberculosispreventivetreatmentamongpatientswithlatenttuberculosisinfectionaqualitativestudy
AT manimarank facilitatorsandbarriersfortuberculosispreventivetreatmentamongpatientswithlatenttuberculosisinfectionaqualitativestudy
AT khooeeming facilitatorsandbarriersfortuberculosispreventivetreatmentamongpatientswithlatenttuberculosisinfectionaqualitativestudy
AT kohwenming facilitatorsandbarriersfortuberculosispreventivetreatmentamongpatientswithlatenttuberculosisinfectionaqualitativestudy